These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 23413422)

  • 1. Stress hypoperfusion and tissue injury in hypertrophic cardiomyopathy: spatial characterization using high-resolution 3-tesla magnetic resonance imaging.
    Tyan CC; Armstrong S; Scholl D; Stirrat J; Blackwood K; El-Sherif O; Thompson T; Wisenberg G; Prato FS; So A; Lee TY; Drangova M; White JA
    Circ Cardiovasc Imaging; 2013 Mar; 6(2):229-38. PubMed ID: 23413422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical significance of late gadolinium enhancement on cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy].
    Dumont CA; Monserrat L; Soler R; Rodríguez E; Fernández X; Peteiro J; Bouzas B; Piñón P; Castro-Beiras A
    Rev Esp Cardiol; 2007 Jan; 60(1):15-23. PubMed ID: 17288951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3.0 T magnetic resonance myocardial perfusion imaging for semi-quantitative evaluation of coronary microvascular dysfunction in hypertrophic cardiomyopathy.
    Yin L; Xu HY; Zheng SS; Zhu Y; Xiao JX; Zhou W; Yu SS; Gong LG
    Int J Cardiovasc Imaging; 2017 Dec; 33(12):1949-1959. PubMed ID: 28612277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microvascular ischemia in hypertrophic cardiomyopathy: new insights from high-resolution combined quantification of perfusion and late gadolinium enhancement.
    Villa AD; Sammut E; Zarinabad N; Carr-White G; Lee J; Bettencourt N; Razavi R; Nagel E; Chiribiri A
    J Cardiovasc Magn Reson; 2016 Jan; 18():4. PubMed ID: 26767610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional Stress-Induced Ischemia in Non-fibrotic Hypertrophied Myocardium in Young HCM Patients.
    Jablonowski R; Fernlund E; Aletras AH; Engblom H; Heiberg E; Liuba P; Arheden H; Carlsson M
    Pediatr Cardiol; 2015 Dec; 36(8):1662-9. PubMed ID: 26066352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary microvascular ischemia in hypertrophic cardiomyopathy - a pixel-wise quantitative cardiovascular magnetic resonance perfusion study.
    Ismail TF; Hsu LY; Greve AM; Gonçalves C; Jabbour A; Gulati A; Hewins B; Mistry N; Wage R; Roughton M; Ferreira PF; Gatehouse P; Firmin D; O'Hanlon R; Pennell DJ; Prasad SK; Arai AE
    J Cardiovasc Magn Reson; 2014 Aug; 16(1):49. PubMed ID: 25160568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy caused by mutations in troponin I.
    Moon JC; Mogensen J; Elliott PM; Smith GC; Elkington AG; Prasad SK; Pennell DJ; McKenna WJ
    Heart; 2005 Aug; 91(8):1036-40. PubMed ID: 16020591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular magnetic resonance signs of ischemia in hypertrophic cardiomyopathy.
    Melacini P; Corbetti F; Calore C; Pescatore V; Smaniotto G; Pavei A; Bobbo F; Cacciavillani L; Iliceto S
    Int J Cardiol; 2008 Aug; 128(3):364-73. PubMed ID: 17643520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of delayed enhancement by magnetic resonance to myocardial perfusion by positron emission tomography in hypertrophic cardiomyopathy.
    Bravo PE; Zimmerman SL; Luo HC; Pozios I; Rajaram M; Pinheiro A; Steenbergen C; Kamel IR; Wahl RL; Bluemke DA; Bengel FM; Abraham MR; Abraham TP
    Circ Cardiovasc Imaging; 2013 Mar; 6(2):210-7. PubMed ID: 23418294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial fibrosis severity on cardiac magnetic resonance imaging predicts sustained arrhythmic events in hypertrophic cardiomyopathy.
    Prinz C; Schwarz M; Ilic I; Laser KT; Lehmann R; Prinz EM; Bitter T; Vogt J; van Buuren F; Bogunovic N; Horstkotte D; Faber L
    Can J Cardiol; 2013 Mar; 29(3):358-63. PubMed ID: 22749647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peri-infarct ischemia determined by cardiovascular magnetic resonance evaluation of myocardial viability and stress perfusion predicts future cardiovascular events in patients with severe ischemic cardiomyopathy.
    Tsukiji M; Nguyen P; Narayan G; Hellinger J; Chan F; Herfkens R; Pauly JM; McConnell MV; Yang PC
    J Cardiovasc Magn Reson; 2006; 8(6):773-9. PubMed ID: 17060098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variables associated with contrast-enhanced cardiovascular magnetic resonance in hypertrophic cardiomyopathy: clinical implications.
    Payá E; Marín F; González J; Gimeno JR; Feliu E; Romero A; Ruiz-Espejo F; Roldán V; Climent V; de la Morena G; Valdés M
    J Card Fail; 2008 Jun; 14(5):414-9. PubMed ID: 18514934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extent of myocardial hyperenhancement on late gadolinium-enhanced cardiovascular magnetic resonance correlates with q waves in hypertrophic cardiomyopathy.
    Papavassiliu T; Flüchter S; Haghi D; Süselbeck T; Wolpert C; Dinter D; Kühl H; Borggrefe M
    J Cardiovasc Magn Reson; 2007; 9(3):595-603. PubMed ID: 17365241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and clinical significance of cardiovascular magnetic resonance adenosine stress-induced myocardial perfusion defect in hypertrophic cardiomyopathy.
    Kim EK; Lee SC; Chang SA; Jang SY; Kim SM; Park SJ; Choi JO; Park SW; Jeon ES; Choe YH
    J Cardiovasc Magn Reson; 2020 May; 22(1):30. PubMed ID: 32366254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Diffuse Subendocardial Hypoperfusion on Left Ventricular Cavity Size by
    Yalçin H; Valenta I; Yalçin F; Corona-Villalobos C; Vasquez N; Ra J; Kucukler N; Tahari A; Pozios I; Zhou Y; Pomper M; Abraham TP; Schindler TH; Abraham MR
    Am J Cardiol; 2016 Dec; 118(12):1908-1915. PubMed ID: 27771003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging.
    Petersen SE; Jerosch-Herold M; Hudsmith LE; Robson MD; Francis JM; Doll HA; Selvanayagam JB; Neubauer S; Watkins H
    Circulation; 2007 May; 115(18):2418-25. PubMed ID: 17452610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormalities in T2-weighted cardiovascular magnetic resonance images of hypertrophic cardiomyopathy: regional distribution and relation to late gadolinium enhancement and severity of hypertrophy.
    Abdel-Aty H; Cocker M; Strohm O; Filipchuk N; Friedrich MG
    J Magn Reson Imaging; 2008 Jul; 28(1):242-5. PubMed ID: 18581348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional outcome after revascularization in patients with chronic ischemic heart disease: a quantitative late gadolinium enhancement CMR study evaluating transmural scar extent, wall thickness and periprocedural necrosis.
    Bondarenko O; Beek AM; Nijveldt R; McCann GP; van Dockum WG; Hofman MB; Twisk JW; Visser CA; van Rossum AC
    J Cardiovasc Magn Reson; 2007; 9(5):815-21. PubMed ID: 17891620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Detection and quantification of myocardial fibrosis in hypertrophic cardiomyopathy by contrast-enhanced cardiovascular magnetic resonance].
    Pujadas S; Carreras F; Arrastio X; Leta R; Vila M; Subirana MT; Bayés-Genís A; Pons-Lladó G
    Rev Esp Cardiol; 2007 Jan; 60(1):10-4. PubMed ID: 17288950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of microvascular dysfunction after acute myocardial infarction by cardiovascular magnetic resonance first-pass perfusion and late gadolinium enhancement imaging.
    Yan AT; Gibson CM; Larose E; Anavekar NS; Tsang S; Solomon SD; Reynolds G; Kwong RY
    J Cardiovasc Magn Reson; 2006; 8(6):831-7. PubMed ID: 17060106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.